Laura Brandt

1.6k total citations
56 papers, 1.0k citations indexed

About

Laura Brandt is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Laura Brandt has authored 56 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Public Health, Environmental and Occupational Health and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Laura Brandt's work include Substance Abuse Treatment and Outcomes (17 papers), Opioid Use Disorder Treatment (14 papers) and Prenatal Substance Exposure Effects (8 papers). Laura Brandt is often cited by papers focused on Substance Abuse Treatment and Outcomes (17 papers), Opioid Use Disorder Treatment (14 papers) and Prenatal Substance Exposure Effects (8 papers). Laura Brandt collaborates with scholars based in United States, Austria and United Kingdom. Laura Brandt's co-authors include Sandra D. Comer, Giuliana Alimena, Roland Berger, CD Bloomfield, Daniel Catovsky, Albert de la Chapelle, G.H. Borgström, O. Margaret Garson, Gabriele Fischer and Gabrielle O’Malley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Laura Brandt

53 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Brandt United States 19 363 208 190 151 132 56 1.0k
Emuella Flood United States 25 153 0.4× 177 0.9× 205 1.1× 233 1.5× 126 1.0× 82 2.0k
Freia De Bock Germany 21 393 1.1× 240 1.2× 182 1.0× 43 0.3× 54 0.4× 98 1.2k
Sonia Lee United States 19 178 0.5× 485 2.3× 124 0.7× 184 1.2× 113 0.9× 51 1.4k
Phoebe Lindsey Barton United States 12 292 0.8× 256 1.2× 78 0.4× 132 0.9× 81 0.6× 22 1.0k
M Lloyd-Jones United Kingdom 12 104 0.3× 304 1.5× 80 0.4× 196 1.3× 94 0.7× 18 1.2k
Barbara Hanna United States 14 250 0.7× 187 0.9× 70 0.4× 122 0.8× 98 0.7× 30 979
Hannah Palac United States 18 131 0.4× 156 0.8× 60 0.3× 133 0.9× 129 1.0× 48 1.1k
Laura Sarno Italy 21 335 0.9× 57 0.3× 79 0.4× 151 1.0× 123 0.9× 65 1.4k
Víctor Viana Portugal 20 342 0.9× 93 0.4× 80 0.4× 256 1.7× 67 0.5× 85 1.3k
Zachary Johnson Ireland 15 271 0.7× 281 1.4× 32 0.2× 179 1.2× 130 1.0× 55 1.2k

Countries citing papers authored by Laura Brandt

Since Specialization
Citations

This map shows the geographic impact of Laura Brandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Brandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Brandt more than expected).

Fields of papers citing papers by Laura Brandt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Brandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Brandt. The network helps show where Laura Brandt may publish in the future.

Co-authorship network of co-authors of Laura Brandt

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Brandt. A scholar is included among the top collaborators of Laura Brandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Brandt. Laura Brandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brandt, Laura, et al.. (2024). Empirically contrasting urine drug screening‐based opioid use disorder treatment outcome definitions. Addiction. 119(7). 1289–1300. 3 indexed citations
2.
Brandt, Laura, Mei‐Chen Hu, Edward V. Nunes, & Aimee Campbell. (2023). Exploring the performance of during-treatment substance use outcome measures in predicting longer-term psychosocial functioning and post-treatment abstinence. Drug and Alcohol Dependence. 248. 109918–109918. 2 indexed citations
3.
Brandt, Laura, Mark Shepard, Norbert Forster, et al.. (2023). Implementing quality management strategies improves clinical quality as a voluntary medical male circumcision program in Namibia matures: a process analysis. BMC Health Services Research. 23(1). 1044–1044.
4.
5.
Jones, Jermaine D., Laura Brandt, Denise A. Hien, et al.. (2021). Factor structure and psychometric properties of the Connor–Davidson resilience scale (CD-RISC) in individuals with opioid use disorder. Drug and Alcohol Dependence. 221. 108632–108632. 18 indexed citations
6.
Brandt, Laura, Aimee Campbell, Jermaine D. Jones, et al.. (2021). Emotional Reactions of Trained Overdose Responders who use Opioids following Intervention in an Overdose Event. Substance Abuse. 43(1). 581–591. 4 indexed citations
7.
Brandt, Laura, Takuya Yanagida, Aimee Campbell, et al.. (2021). Multi-informant Implementation and Intervention Outcomes of Opioid Overdose Education and Naloxone Distribution in New York City. PubMed. 1(3). 209–222. 3 indexed citations
8.
Feldacker, Caryl, Laura Brandt, Mark Shepard, et al.. (2021). Adverse event profile and associated factors following surgical voluntary medical male circumcision in two regions of Namibia, 2015–2018. PLoS ONE. 16(10). e0258611–e0258611. 6 indexed citations
9.
López‐Castro, Teresa, et al.. (2021). Experiences, impacts and mental health functioning during a COVID-19 outbreak and lockdown: Data from a diverse New York City sample of college students. PLoS ONE. 16(4). e0249768–e0249768. 74 indexed citations
10.
Brandt, Laura, et al.. (2020). Pharmacotherapeutic strategies for treating cocaine use disorder—what do we have to offer?. Addiction. 116(4). 694–710. 49 indexed citations
11.
Neale, Joanne, Nicola J. Kalk, Stephen Parkin, et al.. (2020). Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis. Journal of Substance Abuse Treatment. 117. 108099–108099. 15 indexed citations
12.
Tamandjou, Cynthia, Laura Brandt, Etienne Nel, et al.. (2020). Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia. PLoS ONE. 15(9). e0238839–e0238839. 3 indexed citations
13.
Brandt, Laura, Jermaine D. Jones, Jeanne M. Manubay, et al.. (2020). Effects of lorcaserin on oxycodone self-administration and subjective responses in participants with opioid use disorder. Drug and Alcohol Dependence. 208. 107859–107859. 26 indexed citations
14.
Brandt, Laura & Loretta P. Finnegan. (2017). Neonatal abstinence syndrome. Current Opinion in Psychiatry. 30(4). 268–274. 11 indexed citations
15.
Brandt, Laura & Gabriele Fischer. (2017). Adult ADHD Is Associated With Gambling Severity and Psychiatric Comorbidity Among Treatment-Seeking Problem Gamblers. Journal of Attention Disorders. 23(12). 1383–1395. 23 indexed citations
16.
Brandt, Laura & Gabriele Fischer. (2017). The prevalence of adult attention deficit/hyperactivity disorder among treatment-seeking problem gamblers. Drug and Alcohol Dependence. 171. e26–e26. 1 indexed citations
17.
Hamunime, Ndapewa, et al.. (2016). “We Are Now Free to Speak”: Qualitative Evaluation of an Education and Empowerment Training for HIV Patients in Namibia. PLoS ONE. 11(4). e0153042–e0153042. 12 indexed citations
18.
19.
O’Malley, Gabrielle, et al.. (2014). Nurse Task Shifting for Antiretroviral Treatment Services in Namibia: Implementation Research to Move Evidence into Action. PLoS ONE. 9(3). e92014–e92014. 18 indexed citations
20.
Bloomfield, CD, Giuliana Alimena, Roland Berger, et al.. (1986). Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia. Blood. 67(2). 415–420. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emuella Flood Breakdown of academic impact, for papers by Freia De Bock Breakdown of academic impact, for papers by Sonia Lee Breakdown of academic impact, for papers by Phoebe Lindsey Barton Breakdown of academic impact, for papers by M Lloyd-Jones Breakdown of academic impact, for papers by Barbara Hanna Breakdown of academic impact, for papers by Hannah Palac Breakdown of academic impact, for papers by Laura Sarno Breakdown of academic impact, for papers by Víctor Viana Breakdown of academic impact, for papers by Zachary Johnson
Rankless by CCL
2026